The stage is being set for a coordinated attack on the patent system under the guise of making international health care more affordable. A newly released United Nations report encourages developing countries to use compulsory licenses to seize drugs, mostly developed in the U.S. The report was quickly followed by two high profile efforts pressuring our government to misinterpret the Bayh-Dole Act, designed to promote public and private sector R&D partnerships, with claims it allows agencies to move against high priced drugs both here and abroad.
